These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2081198)

  • 1. The ADA human gene therapy clinical protocol.
    Hum Gene Ther; 1990; 1(3):327-62. PubMed ID: 2081198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency.
    Blaese RM
    Pediatr Res; 1993 Jan; 33(1 Suppl):S49-53; discussion S53-5. PubMed ID: 8433875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
    Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
    Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
    Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio AG; Notarangelo LD; Gilboa E; Rossini S; O'Reilly RJ; Smith CA
    Hum Gene Ther; 1993 Aug; 4(4):513-20. PubMed ID: 8399494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral-mediated gene transfer into mammalian cells.
    Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
    Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow gene therapy for adenosine deaminase deficiency.
    Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
    Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte gene therapy.
    Culver KW; Anderson WF; Blaese RM
    Hum Gene Ther; 1991; 2(2):107-9. PubMed ID: 1911929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase deficiency.
    Hirschhorn R
    Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions.
    Ferrari G; Rossini S; Nobili N; Maggioni D; Garofalo A; Giavazzi R; Mavilio F; Bordignon C
    Blood; 1992 Sep; 80(5):1120-4. PubMed ID: 1325209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.
    Onodera M; Ariga T; Kawamura N; Kobayashi I; Ohtsu M; Yamada M; Tame A; Furuta H; Okano M; Matsumoto S; Kotani H; McGarrity GJ; Blaese RM; Sakiyama Y
    Blood; 1998 Jan; 91(1):30-6. PubMed ID: 9414266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
    Nespoli L; Porta F; Locatelli F; Aversa F; Carotti A; Lanfranchi A; Gibardi A; Marchesi ME; Abate L; Martelli MF
    Haematologica; 1990; 75(6):546-50. PubMed ID: 2098297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase deficiency and immunodeficiencies.
    Hirschhorn R
    Fed Proc; 1977 Jul; 36(8):2166-70. PubMed ID: 872949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.
    Hoogerbrugge PM; Vossen JM; v Beusechem VW; Valerio D
    Hum Gene Ther; 1992 Oct; 3(5):553-8. PubMed ID: 1420454
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy of the immune system.
    Cournoyer D; Caskey CT
    Annu Rev Immunol; 1993; 11():297-329. PubMed ID: 8476564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y; Ariga T; Ohtsu M
    Nihon Rinsho; 2005 Mar; 63(3):448-52. PubMed ID: 15773344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
    Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
    Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
    Ramsey WJ; Mullen CA; Blaese RM
    Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.